|
||||||||||||||||||||||||||||||||||||||||||||||
![]()
CAS号:25389-94-0
|
英文名称:Kanamycin sulfate, an aminoglycoside bacteriocidal antibiotic which acts by binding to the bacterial 30S ribosomes
分子式
分子量
EINECS号
MDL
Smiles
InChIKey
乙二醇化学百科
基本信息
物化性质
安全信息
生产及用途
Kanamycin sulfate (Kanamycin monosulfate, Ophtalmokalixan)是一种氨基糖苷类化合物,口服有效,可静脉注射,肌肉注射,广泛应用于感染。 Kanamycin sulfate at the concentration above 0.0025% has a significant inhibition on the growth of B. bifidum and has no influence on the other four probiotics at incubation 12 h or 24 h. The optimum selective concentration of kanamycin sulfate in MRS media is 0.005% for selective enumeration of B.bifidum.
The neurons damage of the DCN caused by kanamycin (500 mg/kg/day) is reversible and autophagy is upregulated in the neurotoxic course of kanamycin on DCN through JNK1-mediated phosphorylation of Bcl-2 pathway in rats. The serum BUN and Cr levels are both increased at the 1st day after the period of kanamycin administration. The neurons expressing LC3 are increased at 1, 7 and 14 days after kanamycin administration in comparison to the control group. Kanamycin treatment results in the increase of autophagy in a time-dependent manner. Kanamycin sulfate (5 mg/kg) and sodium ampicillin (10 mg/kg) administered intramuscularly (i.m.) separately, and then together, to five pony mares, and the ampicillin concentration exceeds 5 mg/mL in inflamed synovial fluid for some 2.5 h after injection, and kanamycin sulfate concentration exceeds 2 mg/mL for 7 h in the pony.
用途 用于治疗食道炎、胃窦炎、细菌性痢疾及消化道感染用途 生化研究用途 生物技术的应用,以抑制蛋白质的合成。用于转化细胞用卡那霉素B(neoR,KanR表型)抗性基因作为选择剂。
相关产品
|
||||||||||||||||||||||||||||||||||||||||||||||